Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00460764
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
GTX | S-HEXYLGLUTATHIONE | A,B | 1K3Y | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 1AGS | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 1PN9 | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 1Q4J | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 2IMK | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 4GSS | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B,C | 1GWC | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B,C,D | 2C3Q | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B,C,D | 1TU8 | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 2GLR | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 2OA7 | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,C | 2AAW | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 1VF2 | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A | 1M9A | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 17GS | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 1K0A | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 2R3X | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 1GSU | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 2C80 | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 2R6K | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 1PGT | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 2J9H | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 1K3L | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 1GNW | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B,C,D | 1BH5 | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 1YDK | 0.71 | |
GTX | S-HEXYLGLUTATHIONE | A,B | 9GSS | 0.71 | |
GSM | L-GAMMA-GLUTAMYL-S-METHYLCYSTEINYLGLYCINE | A,B,C,D | 2AB6 | 0.7 | |
AFJ | (2R,4S,5S)-N-butyl-4-hydroxy-2,7- dimethyl-5-{[N-(4-methylpentanoyl)- L-methionyl]amino}octanamide | A,B,C | 3DUY | 0.72 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 2BJS | 0.72 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1QJE | 0.72 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BK0 | 0.72 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BLZ | 0.72 | |
W05 | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-D-ALANINE | A | 1W05 | 0.7 | |
W05 | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-D-ALANINE | A | 1W06 | 0.7 | |
ACW | D-(L-A-AMINOADIPOYL)-L-CYSTEINYL- B-METHYL-D-CYCLOPROPYLGLYCINE | B | 2IVI | 0.71 | |
VB1 | N^6^-[(1R)-2-{[(1S)-1-carboxypropyl]amino}- 2-oxo-1-(sulfanylmethyl)ethyl]- 6-oxo-L-lysine | A | 2VBP | 0.7 | |
EPM | N-PALMITOYL-L-METHIONINE | A,B | 1ZO9 | 0.75 | |
AXQ | {(E)-(3R,6S,9R)-3-[(1S,3R)-3-((S)- 1 -BUTYLCARBAMOYL-2-METHYL-PROPYLCARB AMOYL)- 1-HYDROXY-BUTYL]-6-METHYL-5, 8- DIOXO-1,11-DITHIA-4,7-DIAZA-CYCLO PENTADEC- 13-EN-9-YL}-CARBAMIC ACID TERT- BUTYL ESTER | A,B,C | 2F3E | 0.71 | |
HEL | (2S,5R,6R)-6-{[(6R)-6-(GLYCYLAMINO)- 7-OXIDO-7-OXOHEPTANOYL]AMINO}-3,3- DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLATE | A | 1PWG | 0.72 | |
HEL | (2S,5R,6R)-6-{[(6R)-6-(GLYCYLAMINO)- 7-OXIDO-7-OXOHEPTANOYL]AMINO}-3,3- DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLATE | A | 1PW1 | 0.72 | |
ACC | N-[N-[2-AMINO-6-OXO-HEXANOIC ACID- 6-YL]CYSTEINYL]-S-METHYLCYSTEINE | A | 1QIQ | 0.73 | |
GTY | L-GAMMA-GLUTAMYL-S-OCTYL-D-CYSTEINYLGLYCINE | A | 1U88 | 0.71 | |
HJ3 | (2R,4S)-2-[(1R)-1-{[(6S)-6-amino- 6-carboxyhexanoyl]amino}-2-oxoethyl]- 5,5-dimethyl-1,3-thiazolidine-4- carboxylic acid | A | 3BEB | 0.72 |